cancer
gene
therapi
great
promis
tool
cancer
therapeut
due
specif
target
base
cancer
gene
express
background
binari
system
base
sitespecif
recombin
one
effect
potenti
approach
cancer
gene
therapi
system
cancer
specif
promot
express
sitespecif
recombinaseintegras
turn
control
express
toxin
gene
current
studi
develop
new
bacteriophag
integras
int
base
binari
system
activ
diphtheria
toxin
dta
gene
express
specif
cancer
cell
demonstr
effici
high
specif
system
vitro
cell
cultur
vivo
lung
cancer
mous
model
strikingli
differ
apoptot
antiapoptot
factor
demonstr
remark
efficaci
kill
capabl
intbas
binari
system
compar
convent
htertdta
mono
system
llckat
lung
cancer
mice
model
observ
activ
htert
promot
regul
transcript
factor
cornerston
phenomenon
new
intbas
binari
system
offer
advantag
alreadi
known
counterpart
may
therefor
develop
safer
effici
cancer
treatment
technolog
technolog
cancer
therapi
approach
four
main
direct
radiat
therapi
xrt
ii
chemotherapi
iii
immunotherapi
iv
gene
therapi
despit
xrt
common
use
associ
signific
side
effect
normal
tissu
organ
limit
dosag
locat
use
similarli
use
convent
cancer
drug
chemotherapi
also
serious
side
effect
healthi
cell
organ
whole
organ
main
reason
harm
consequ
lack
tumor
specif
moreov
primari
intrins
andor
acquir
multidrug
resist
one
main
obstacl
success
cancer
treatment
success
target
immun
checkpoint
unleash
antitumor
cell
respons
result
durabl
longlast
respons
howev
cancer
immunotherapi
help
fraction
patient
probabl
combin
therapi
promis
effect
approach
cancer
treatment
gene
therapi
definit
one
import
develop
field
cancer
treatment
sinc
earli
nineti
one
first
studi
done
zvi
ram
technolog
mani
research
current
advanc
stage
clinic
trial
main
advantag
gene
therapi
approach
potenti
use
target
deliveri
mainli
classifi
two
differ
strategi
passiv
target
activ
target
enhanc
permeat
retent
epr
basi
passiv
cancer
target
wide
appli
numer
drug
deliveri
system
cancer
target
wherea
activ
target
basic
concept
util
molecular
target
agent
specif
target
biomark
receptor
cancer
cell
addit
advantag
gene
therapi
approach
tumorspecif
express
strategi
avoid
harm
normal
tissu
howev
develop
tool
still
repres
signific
challeng
toxin
therapi
approach
part
cancer
gene
therapi
base
toxic
gene
express
target
exclus
cancer
cell
result
kill
apoptosi
without
affect
healthi
cell
show
zvi
ram
one
use
toxin
cancer
gene
therapi
diphtheria
toxin
dt
corynebacterium
diphtheria
dta
belong
ab
type
iii
group
exotoxin
catalyz
adpribosyl
elong
henc
arrest
protein
synthesi
induc
cell
death
dta
effici
kill
activ
rate
singl
dta
molecul
suffici
kill
cell
former
studi
demonstr
select
express
dta
tumor
cell
use
cancer
specif
promot
main
drawback
approach
incomplet
specif
promot
activ
cancer
cell
wherea
residu
express
result
cytotox
effect
also
healthi
cell
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
har
sitespecif
recombinas
ssr
genom
manipul
gene
therapi
wellknown
approach
past
year
system
encod
recombinas
catalyz
sitespecif
recombin
two
specif
short
dna
sequenc
base
pair
bp
serv
recombin
site
rs
sitespecif
integras
int
coliphag
catalyz
phage
integr
excis
e
coli
host
chromosom
mechan
sitespecif
recombin
reaction
ident
well
document
int
coliphag
lambda
host
recombin
site
attb
bp
long
phage
attp
recombin
site
bp
long
compos
bp
core
similar
attb
flank
two
long
arm
p
p
carri
bind
site
int
accessori
dnabend
protein
includ
bacteri
integr
host
factor
ihf
integr
attb
x
attp
recombin
result
integr
phage
host
genom
result
prophag
flank
recombin
attl
attr
site
integr
could
revers
process
term
excis
also
catalyz
int
demonstr
int
activ
human
cell
site
specif
recombinas
also
exploit
binari
system
toxin
specif
express
cancer
cell
base
two
dna
plasmid
one
recombinas
substrat
carri
toxin
gene
silenc
transcript
termin
locat
two
recombin
site
second
plasmid
carri
recombinas
gene
express
cancer
specif
promot
promot
provid
express
recombinas
cancer
cell
excis
termin
thu
activ
toxin
express
shown
previous
int
much
less
activ
eukaryot
cell
compar
flp
cre
site
specif
recombinas
current
wide
use
genom
manipul
higher
organ
unpublish
fact
design
activ
silent
substrat
binari
system
case
int
demand
consider
higher
quantiti
enzym
reach
cancer
cell
high
level
activ
cancer
specif
promot
case
healthi
cell
possibl
leakag
cancer
promot
may
lead
basic
level
int
express
obvious
insuffici
silent
substrat
activ
case
much
activ
recombinas
even
insignific
level
basic
express
healthi
cell
may
lead
substrat
activ
toxin
express
healthi
cell
describ
int
activ
finetun
binari
system
insur
high
efficaci
safeti
level
toxin
base
cancer
therapi
technolog
recent
develop
int
base
binari
express
system
demonstr
increas
specif
human
cancer
cell
lung
cancer
mous
model
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
use
luciferas
report
demonstr
applic
int
base
binari
system
use
dta
toxin
express
specif
kill
tumor
cell
cancer
therapi
bacteri
host
use
e
coli
strain
lacz
grown
plate
luriabertani
lb
rich
medium
appropri
antibiot
plasmid
transform
perform
electropor
plasmid
oligom
list
tabl
mice
procedur
perform
complianc
tel
aviv
univers
guidelin
protocol
approv
institut
anim
care
use
committe
strain
use
mice
experi
experi
least
repeat
tri
time
construct
dta
carri
plasmid
use
less
toxic
mutant
plasmid
carri
cmvattrstopattldta
cassett
stoptranscript
termin
construct
ligat
ageinoti
dta
pcr
fragment
obtain
use
kindli
provid
dr
maxwel
f
templat
primer
tabl
list
oligom
site
plasmid
carri
dta
gene
control
htert
promot
construct
ligat
ageibluntednoti
dta
fragment
hindiiibluntednoti
fragment
plasmid
carri
dta
gene
control
cmv
promot
construct
ligat
ageinoti
dta
fragment
site
plasmid
use
sitespecif
recombin
substrat
dta
toxin
assay
control
htert
promot
htertattrstopattldta
construct
ligat
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
nheibluntedagei
attrstopattl
fragment
ageinoti
dta
fragment
hindiiibluntednoti
fragment
plasmid
construct
verifi
dna
sequenc
tabl
list
plasmid
estim
int
depend
dta
toxin
activ
appropri
cell
cultur
describ
cotransfect
gfp
report
plasmid
sitespecif
recombin
substrat
plasmid
ng
int
express
plasmid
posit
control
gfp
express
cell
transfect
plasmid
posit
control
dta
activ
cell
cotransfect
plasmid
plasmid
carri
dta
gene
control
cmv
nontissu
specif
express
htert
promot
cancer
specif
express
ng
neg
control
int
depend
dta
toxin
activ
cell
cotransfect
report
plasmid
sitespecif
recombin
substrat
plasmid
ng
cotransfect
perform
total
dna
quantiti
forward
sidescatt
profil
obtain
sampl
dna
deliveri
mice
perform
use
linear
polyethylenimin
base
deliveri
reagent
vivojet
pei
polyplu
transfect
franc
previous
describ
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
prepar
section
immunohistochemistri
confoc
microscopi
apoptosi
tunel
assay
imag
analysi
prepar
section
confoc
microscopi
apoptosi
tunel
assay
imag
analysi
perform
previous
describ
healthi
cancer
lung
carri
metastas
immunestain
antidta
cat
virostat
portland
usa
cleav
cat
total
rna
isol
murin
lung
ezrna
isol
kit
biolog
industri
beit
haemek
israel
cdna
synthes
use
verso
cdna
kit
appli
biosystem
foster
citi
ca
mrna
express
assess
stepon
quantit
realtim
pcr
system
appli
biosystem
foster
citi
ca
qrtpcr
mous
katushka
bax
mrna
carri
detail
primer
given
tabl
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
order
normal
express
bax
gene
accord
katushka
cell
distribut
murin
lung
absolut
quantif
aq
method
appli
method
base
standard
curv
known
quantiti
comparison
unknown
quantiti
standard
curv
extrapol
express
valu
first
total
number
mrna
molecul
katushka
bax
calcul
accord
express
use
formula
dna
x
pg
x
x
pmol
dna
number
bax
molecul
divid
number
katushka
mrna
molecul
order
normal
gene
express
one
katushka
molecul
plasmid
dna
e
coli
prepar
use
dna
spin
plasmid
dna
purif
kit
intron
biotechnolog
korea
nucleobond
tm
xtra
maxi
plu
ef
kit
machereynagel
germani
gener
genet
engin
experi
perform
describ
sambrook
russel
data
present
mean
sd
pvalu
less
consid
statist
signific
student
twotail
test
assum
equal
varianc
previous
demonstr
valid
int
activ
cancer
specif
binari
cell
express
system
luc
report
report
applic
level
specif
int
activ
binari
system
use
dta
toxin
kill
cancer
cell
henceforth
binari
system
binari
system
consist
two
plasmid
express
int
gene
control
cancer
specif
htert
promot
activ
practic
type
tumor
immort
cell
silent
somat
tissu
second
plasmid
carri
silent
open
read
frame
dta
gene
separ
htert
promot
transcript
termin
stop
flank
tandem
attr
attl
recombin
site
intcatalyz
attr
x
attl
recombin
excis
termin
sequenc
therebi
allow
express
toxin
promot
binari
system
express
gene
int
dta
regul
htert
promot
posit
control
dta
toxic
cell
cultur
use
plasmid
express
dta
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
gene
constitut
strong
human
cytomegaloviru
promot
cmv
exanim
effici
binari
system
versu
convent
mono
dtabas
cancer
gene
therapi
approach
use
plasmid
carri
dta
gene
control
htert
promot
effici
specif
int
activ
binari
system
tissu
cultur
first
examin
toxic
activ
less
activ
dta
mutant
base
abil
abolish
translat
green
fluoresc
protein
gfp
report
cell
cultur
cell
line
llckat
bj
cotransfect
three
plasmid
silent
dta
substrat
plasmid
carri
htert
promoterattrstopattldta
cassett
henceforth
sub
htertint
express
plasmid
egfpexpress
plasmid
cell
transfect
two
control
plasmid
one
verifi
dta
activ
use
cmvdta
second
carri
htertdta
express
plasmid
cotransfect
egfp
report
plasmid
assess
essenti
silenc
sub
cell
fig
grey
column
cell
use
previou
report
develop
lungmetastat
tumor
mice
data
cell
line
also
demonstr
toxic
cell
transfect
silent
sub
alon
surviv
cell
show
nonsignific
differ
posit
control
fig
gray
column
sub
cell
show
strong
toxic
surviv
cell
cmvdta
plasmid
signific
toxic
mono
htertdta
binari
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
system
fig
gray
column
note
dta
activ
vitro
llckat
cell
lower
cell
fig
grey
black
column
cmvdta
third
treat
cell
line
bj
consist
normal
human
foreskin
fibroblast
cell
aim
examin
cancer
specif
efficaci
htert
promot
fig
white
column
data
cell
line
also
show
toxic
cell
transfect
silent
sub
alon
surviv
cell
fig
white
column
sub
cell
show
strong
toxic
surviv
cell
cmvdta
plasmid
signific
toxic
mono
htertdta
fig
white
column
hand
binari
system
driven
htert
promot
demonstr
toxic
compar
cell
transfect
pegfp
alon
fig
white
column
sub
htertint
result
clearli
show
int
base
dta
express
system
highli
effici
kill
lung
cancer
cell
vitro
present
highli
safeti
function
normal
cell
dta
express
found
essenti
silenc
probabl
due
transcript
stop
sequenc
next
stage
want
examin
cancer
specif
efficaci
kill
well
safeti
intbas
binari
system
whole
organ
vivo
mice
treat
binari
system
therapeut
effect
assess
hour
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
compar
quantit
analysi
dta
express
level
ihc
llckat
mice
lung
reveal
fold
dta
immun
detect
develop
intbas
system
htertdta
mono
system
fig
e
detect
substanti
increas
dta
express
healthi
mice
treat
htertdta
plasmid
compar
mice
treat
intbas
binari
dta
express
system
demonstr
highli
efficaci
safeti
binari
system
fig
e
sinc
dta
express
induc
apoptosi
follow
experi
level
apoptot
effect
analyz
lung
specimen
healthi
llckat
lung
cancer
mice
use
ihc
western
blot
quantit
realtim
pcr
qrt
pcr
method
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
mous
lung
singl
cell
analysi
ihc
analysi
doubl
immunostain
use
antibodi
katushka
dta
fig
red
green
respect
llckat
mice
treat
intbas
binari
system
present
signific
amount
dta
cytoplasm
singl
cancer
cell
demonstr
high
level
express
dta
toxin
cancer
cell
fig
subhtertint
respect
fig
show
katushka
pattern
detect
cancer
lung
sampl
confirm
cancer
develop
erkph
prolifer
marker
abund
decreas
lung
mice
treat
binari
system
compar
untreat
mice
fig
hand
apoptot
marker
jnkph
show
essenti
increas
abund
lung
mice
treat
binari
system
fig
differenti
level
apoptot
prolifer
marker
llckat
cancer
mice
treat
intbas
system
compar
untreat
mice
present
effici
appli
cancer
treatment
sinc
dta
express
induc
apoptosi
describ
use
qrt
pcr
want
analyz
minitranscriptom
follow
gene
bax
function
character
apoptosispromot
factor
character
apoptosissuppress
factor
llckat
cancer
lung
treat
binari
system
b
c
respect
analysi
demonstr
level
bax
gene
transcript
cancer
treat
lung
much
higher
cancer
untreat
lung
moreov
qrtpcr
analysi
also
demonstr
increas
ratio
llckat
cancer
lung
treat
binari
system
compar
untreat
lung
ratio
describ
cellular
rheostat
apoptosi
sensit
sens
intracellular
ratio
protein
profoundli
influenc
abil
cell
respond
apoptot
signal
accord
concept
cell
high
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
ratio
sensit
given
apoptot
stimuli
compar
similar
cell
type
compar
low
ratio
fig
paper
develop
anticanc
binari
system
base
sitespecif
recombin
reaction
catalyz
int
activ
express
dta
toxin
gene
specif
cancer
cell
without
affect
neighbor
normal
cell
compar
analys
intbas
binari
htertdta
mono
system
healthi
mice
reveal
unexpect
substanti
dta
express
mice
treat
htertdta
plasmid
result
nonspecif
htert
promot
leakag
led
activ
apoptosi
indic
apoptot
marker
tunel
demonstr
poor
safeti
mono
system
fig
panel
e
contrast
intbas
binari
system
caus
similar
nonspecif
effect
result
demonstr
efficaci
safeti
binari
system
toward
normal
vs
cancer
cell
fig
panel
e
describ
compar
quantit
analysi
dta
express
level
llckat
mice
lung
intbas
binari
system
reveal
elev
fold
dta
mono
system
fig
e
actual
intcatalyz
attr
x
attl
recombin
remov
termin
sequenc
silent
substrat
produc
htertattbdta
product
plasmid
differ
htertdta
plasmid
presenc
short
bp
attb
sequenc
promot
dta
gene
propos
differ
dta
express
two
plasmid
may
explain
htert
promot
differenti
regul
binari
mono
system
llckat
cancer
cell
htert
promot
regul
express
human
telomeras
revers
transcriptas
htert
gene
product
part
enzym
telomeras
togeth
rna
subunit
telomeraseassoci
protein
wherea
rna
subunit
telomeras
express
cell
htert
express
repress
normal
cell
tumor
cell
htert
transcript
upregul
thu
htert
express
result
telomeras
activ
critic
tumorigenesi
furthermor
inhibit
telomeras
activ
lead
senesc
apoptosi
tumor
cell
indic
telomeras
activ
requir
longterm
viabil
tumor
cell
one
signific
regulatori
element
htert
promot
sequenc
e
box
bind
site
mycmaxmad
network
basic
helixloophelixleucin
zipper
transcript
factor
role
variou
aspect
cell
behavior
includ
prolifer
differenti
apoptosi
central
max
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
suggest
appear
high
concentr
activ
exogen
htert
promot
provid
htertdta
plasmid
caus
sharp
chang
activ
htert
intracellular
balanc
result
immedi
repress
differ
transcript
factor
activ
includ
hand
htert
promot
plasmid
silent
dta
substrat
binari
system
activ
due
intervent
insert
transcript
termin
case
balanc
activ
htert
promot
cell
remain
invari
consequ
silent
dta
substrat
activ
intcatalyz
sitespecif
recombin
llckat
cancer
cell
lead
format
signific
amount
htertattbdta
product
result
essenti
chang
balanc
activ
htert
promot
howev
amount
product
suffic
dta
synthesi
cancer
cell
lead
high
efficaci
kill
activ
describ
result
test
propos
suggest
perform
analysi
express
level
healthi
lung
cancer
mice
ihc
use
ab
fig
b
data
unambigu
demonstr
suggest
activ
htert
intracellular
regul
caus
activ
elev
suppressor
regul
differ
transcript
factor
regul
htert
promot
might
involv
one
int
distinct
significantli
increas
specif
effici
binari
system
human
cell
int
activ
depend
host
encod
integr
host
factor
ihf
phageencod
excisionas
xi
e
coli
shown
contrast
requir
int
ihf
xi
natur
milieu
wild
type
int
activ
human
cell
without
need
suppli
accessori
protein
howev
addit
protein
improv
int
activ
human
cell
similar
result
also
receiv
int
lambda
human
cell
express
singl
chain
ihf
strengthen
wild
type
activ
level
ihfindepend
mutant
vitro
experi
also
show
human
chromatinassoci
protein
substitut
extent
requir
accessori
protein
result
state
allow
assum
definit
histon
histonelik
chromatinassoci
protein
render
strengthen
effect
int
activ
human
cell
intriguingli
express
human
histon
histonelik
protein
cenpa
upregul
numer
cancer
data
allow
suggest
int
activ
may
strengthen
human
cancer
cell
compar
healthi
cell
put
histon
histonelik
int
accessori
protein
upregul
phenomenon
int
cancer
specif
activ
via
accessori
protein
significantli
increas
specif
effici
intbas
binari
system
provid
addit
advantag
compar
convent
mono
system
human
cancer
therapi
cancer
gene
therapi
studi
suggest
consid
regul
element
crucial
signific
factor
activ
effici
develop
approach
binari
anticanc
system
belong
toxin
gene
deliveri
approach
obviou
advantag
compar
convent
toxin
deliveri
approach
show
higher
safeti
efficaci
healthi
cell
higher
kill
efficaci
cancer
cell
moreov
unlik
system
use
dna
vector
mammalian
gene
manipul
viralfre
binari
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
system
may
strong
impact
human
cancer
cure
preclin
trial
includ
examin
binari
system
surviv
experi
progress
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
tabl
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
tabl
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
